![Antonin Rollet de Fougerolles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Antonin Rollet de Fougerolles
Director/Miembro de la Junta en
DEEPMATTER GROUP PLC
.
Perfil
Antonin Rollet de Fougerolles is currently the Chairman at eTheRNA immunotherapies NV.
He is also a Director at Chimeron Bio Corp., Walking Fish Therapeutics, Inc., and a Non-Executive Director at ChemAI Ltd. Previously, he served as the Chief Executive Officer & Director at Evox Therapeutics Ltd. from 2018 to 2024.
He was the Chief Scientific Officer at Tolerx, Inc. in 2010-2011 and at Ablynx NV from 2013 to 2018.
Additionally, he held the position of VP-Research, Immunology, Metabolic & Viral Disease at Alnylam Pharmaceuticals, Inc. from 2009 to 2010.
Dr. de Fougerolles obtained a doctorate degree from Harvard University.
Cargos activos de Antonin Rollet de Fougerolles
| Empresas | Cargo | Inicio |
|---|---|---|
| DEEPMATTER GROUP PLC | Director/Miembro de la Junta | 27/11/2024 |
Walking Fish Therapeutics, Inc.
 Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Director/Miembro de la Junta | - |
Chimeron Bio Corp.
 Chimeron Bio Corp. Medical SpecialtiesHealth Technology Develops personalized immuno therapeutics for the treatment of cancer | Director/Miembro de la Junta | - |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Presidente | 10/07/2024 |
Antiguos cargos conocidos de Antonin Rollet de Fougerolles.
| Empresas | Cargo | Fin |
|---|---|---|
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Director Ejecutivo | 29/04/2024 |
| ABLYNX | Director Técnico/Científico/I+D | 01/02/2018 |
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Director Técnico/Científico/I+D | 19/12/2011 |
| ALNYLAM PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/01/2010 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Director Técnico/Científico/I+D | - |
Formación de Antonin Rollet de Fougerolles.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
66
Relaciones de 1er grado
10
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
DeepMatter Group Plc
 DeepMatter Group Plc Packaged SoftwareTechnology Services Develops AI-powered predictive chemistry solutions | Technology Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Health Technology |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Health Technology |
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Develops personalized immuno therapeutics for the treatment of cancer | Health Technology |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Health Technology |
- Bolsa de valores
- Insiders
- Antonin Rollet de Fougerolles
